Status:

COMPLETED

Investigation of Heylo, a Novel App Driven Digital Supporting Ostomy Product

Lead Sponsor:

Coloplast A/S

Conditions:

Ileostomy - Stoma

Colostomy Stoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

People with intestinal stomas can have, despite development of better ostomy products, problems with leakage which influence their quality of life negatively. To overcome this, Coloplast has develope...

Detailed Description

The Investigational device - Heylo, is already CE-marked. The investigation is an open-labelled, randomized cross-over trial with two test periods evaluating Heylo and Standard of Care. In total 144...

Eligibility Criteria

Inclusion

  • Has given written consent to participate by signing the Informed Consent Signature Form.
  • Is at least 18 years of age and has full legal capacity.
  • Has an ileostomy or colostomy with consistent liquid/mushy fecal output (5-7 Bristol scale\*)
  • Is able to use one of the five test products (i.e. Ø40, Ø50, Ø60, Ø70, Ø80 mm).
  • Has experienced leakage\*\* under the baseplate at least three times within the last fourteen days. \*\*Leakage defined as output seeping under the baseplate"
  • Has worry about leakage to "some degree, high degree, or very high degree" (on a five-point Likert scale: Very low degree/Not at all, Low degree, some degree, High degree, very high degree)
  • Is willing to refrain from use of ostomy paste.
  • Has a smartphone compatible with the Heylo™ application
  • Is able to follow study procedures for 4 months (assessed by investigator or delegate)

Exclusion

  • Is participating in other clinical investigations or has previously participated in this investigation
  • Is pregnant or breastfeeding
  • Has known hypersensitivity towards any of the products used in the investigation
  • Is using/ has a pacemaker

Key Trial Info

Start Date :

January 13 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 4 2022

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT05200416

Start Date

January 13 2022

End Date

November 4 2022

Last Update

January 23 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Peter C. Ambe

Bergisch Gladbach, Bergisch Gladbach,Nordrhein-Westfalen, Germany, 51429